VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $432 | -94.0% | 100 | -90.9% | 0.00% | – |
| Q2 2023 | $7,249 | -2.9% | 1,100 | 0.0% | 0.00% | – |
| Q1 2023 | $7,469 | -8.1% | 1,100 | 0.0% | 0.00% | – |
| Q4 2022 | $8,129 | -18.7% | 1,100 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | -9.1% | 1,100 | 0.0% | 0.00% | – |
| Q2 2022 | $11,000 | +1000.0% | 1,100 | +1000.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -100.0% | 100 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $6,981,000 | -71.6% | 379,404 | -59.6% | 0.04% | -73.9% |
| Q4 2018 | $24,545,000 | +29.6% | 939,374 | +13.8% | 0.15% | +51.5% |
| Q3 2018 | $18,942,000 | +3.9% | 825,375 | -13.7% | 0.10% | -3.8% |
| Q2 2018 | $18,228,000 | +607500.0% | 956,866 | +478333.0% | 0.10% | – |
| Q1 2018 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2017 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2015 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q4 2014 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2014 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
| Q2 2014 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2014 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q4 2013 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |